Nevertheless, pharmacological inhibition blocks MET activation in both cancer cells and cells populating the tumor microenvironment, while genetic manipulation resulting in MET knock-out in cancer cells narrows down the analysis to the tumor, allowing the dissection of cell-autonomous and non-cell-autonomous functions. The gene discussed is MET; the disease is neoplasm.